
Baxter International ownership: holders and insider trading
$25.81+0.27%Close 13 Nov 2026 · Market value $13.28B
As filed, 685 institutional managers reported holding 100.0% at 30 Jun 2026. Insiders made no open-market purchase or sale over the last twelve months.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| BlackRock | Institution | 81.8M | 15.82%* | Form 13F | 30 Jun 2026 |
|---|
| Pzena Investment Management LLC | Institution | 65.3M | 12.62%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard | Institution | 62.5M | 12.07%* | Form 13F | 30 Jun 2026 |
|---|
| Dodge & Cox | Institution | 58.4M | 11.29%* | Form 13F | 30 Jun 2026 |
|---|
| Fidelity (FMR) | Institution | 53.9M | 10.42%* | Form 13F | 30 Jun 2026 |
|---|
| FMR LLC | Holder | 53.0M | 10.3% | Schedule 13G | 29 May 2026 |
|---|
| Vanguard Capital Management | Holder | 38.0M | 7.36% | Schedule 13G | 31 Mar 2026 |
|---|
| BlackRock Portfolio Management LLC | Holder | 30.4M | 5.9% | Schedule 13G | 30 Sep 2026 |
|---|
| State Street | Institution | 20.6M | 3.98%* | Form 13F | 30 Jun 2026 |
|---|
| Greenhaven Associates Inc | Institution | 14.3M | 2.76%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 14.1M | 2.73%* | Form 13F | 30 Jun 2026 |
|---|
| Invesco | Institution | 12.4M | 2.39%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 11.0M | 2.13%* | Form 13F | 30 Jun 2026 |
|---|
| First Pacific Advisors, LP | Institution | 7.6M | 1.47%* | Form 13F | 30 Jun 2026 |
|---|
| Goldman Sachs | Institution | 7.2M | 1.38%* | Form 13F | 30 Jun 2026 |
|---|
| Equity Investment Corp | Institution | 6.9M | 1.33%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 6.4M | 1.23%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 6.2M | 1.21%* | Form 13F | 30 Jun 2026 |
|---|
| State Farm Mutual Automobile Insurance Co | Institution | 6.2M | 1.20%* | Form 13F | 30 Jun 2026 |
|---|
| Charles Schwab | Institution | 6.0M | 1.16%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Hider Andrew P. · President and CEO · Director | 2 Sep 2026 | Shares withheld for tax | −54.3K | $25.70 | $1.39M |
|---|
| Foster Julie · President, Front Line Care | 2 Sep 2026 | Shares withheld for tax | −2.1K | $25.70 | $53.92K |
|---|
| Teaff James · President, CCS | 1 Sep 2026 | Shares withheld for tax | −750 | $25.48 | $19.11K |
|---|
| Wallace Steven P. · President, Adv. Surgery | 2 Jun 2026 | Shares withheld for tax | −153 | $18.68 | $2.86K |
|---|
| Teaff James · President, CCS | 2 Jun 2026 | Shares withheld for tax | −321 | $18.68 | $6.00K |
|---|
| Zielinski Anita A · SVP, Interim CFO, CAO & Cntrlr | 1 Jun 2026 | Grant or award | +13.4K | — | — |
|---|
| Wilkes David S. · Director | 5 May 2026 | Grant or award | +12.8K | — | — |
|---|
| Wendell Amy McBride · Director | 5 May 2026 | Grant or award | +12.8K | — | — |
|---|
| SCHLICHTING NANCY M · Director | 5 May 2026 | Grant or award | +12.8K | — | — |
|---|
| MORRISON PATRICIA · Director | 5 May 2026 | Grant or award | +12.8K | — | — |
|---|
| Shafer David Brent · Director · Chair of the Board | 5 May 2026 | Grant or award | +12.8K | — | — |
|---|
| McDonnell Michael R. · Director | 5 May 2026 | Grant or award | +12.8K | — | — |
|---|
| Craig Jeffrey A · Director | 5 May 2026 | Grant or award | +12.8K | — | — |
|---|
| Ampofo William A. II · Director | 5 May 2026 | Grant or award | +12.8K | — | — |
|---|
| Zielinski Anita A · SVP, CAO and Controller | 6 Mar 2026 | Shares withheld for tax | −1.9K | $17.69 | $34.18K |
|---|
| Soriano Maria Cecilia · Group Pres., ITT & Pharma. | 6 Mar 2026 | Shares withheld for tax | −2.8K | $17.69 | $50.38K |
|---|
| Rosenbloom David S. · EVP and General Counsel | 6 Mar 2026 | Shares withheld for tax | −6.6K | $17.69 | $117.1K |
|---|
| Rasul Reazur · EVP,Group Pres,Healthcare | 6 Mar 2026 | Shares withheld for tax | −12.7K | $17.69 | $224.2K |
|---|
| Grade Joel T. · EVP and CFO | 6 Mar 2026 | Shares withheld for tax | −8.2K | $17.69 | $144.2K |
|---|
| Rasul Reazur · EVP,Group Pres,Healthcare | 2 Mar 2026 | Shares withheld for tax | −1.6K | $19.69 | $31.78K |
|---|
| Soriano Maria Cecilia · Group Pres., ITT & Pharma. | 2 Mar 2026 | Shares withheld for tax | −1.9K | $19.69 | $36.47K |
|---|
| Rosenbloom David S. · EVP and General Counsel | 2 Mar 2026 | Shares withheld for tax | −1.3K | $19.69 | $26.31K |
|---|
| Hider Andrew P. · President and CEO · Director | 27 Feb 2026 | Grant or award | +202K | — | — |
|---|
| Carlisle Cynthia · Executive Vice President, CHRO | 27 Feb 2026 | Grant or award | +17.8K | — | — |
|---|
| Carlisle Cynthia · Executive Vice President, CHRO | 27 Feb 2026 | Grant or award | +11.9K | — | — |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
BAX in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.